Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study

Autor: Cindy Kenis, Lore Decoster, Johan Flamaing, Philip R. Debruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, Heidi Van den Bulck, Dirk Schrijvers, Christine Langenaeken, Pol Specenier, Guy Jerusalem, Jean-Philippe Praet, Jessie De Cock, Jean-Pierre Lobelle, Hans Wildiers, Koen Milisen

Publikováno v: BMC Geriatrics, Vol 22, Iss 1, Pp 1-14 (2022)

Abstract Background Falls and fall-related injuries are a major public health problem. Data on falls in older persons with cancer is limited and robust data on falls within those with a frailty profile are missing. The aim of this study is to investi

Externí odkaz: https://doaj.org/article/bf52381393b7483d81bf534bf0fcbe9e

Abstract P2-14-12: B-immune interim analysis: A phase Ib/II study of durvalumab combined with dose-dense EC in a neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers

Autor: Javier Carrasco, Claire Quaghebeur, Stephanie Henry, Christine Galant, Mieke Van Bockstal, Paul Delrée, Brigitte Honhon, Dominique Korman, Vincent Verschaeve, Christophe Lonchay, Sarah Levefre, Lionel D'hondt, Martine Berliere, Sophie Delmarcelle, Jean-Michel Mine, Timour Willems, Gebhard Müller, Nathalie Myant, Isabelle Bar, Manuel Constant, Sandy Haussy, Alix Devaux, Pierre Coulie, Jean-Luc Canon, François Duhoux

Publikováno v: Cancer Research. 82:P2-14

Background: The association of immune checkpoints inhibitors (ICI) and dose dense chemotherapy is a promising combination in a neoadjuvant setting for triple negative breast cancers (TNBC). However, response rates vary from one study to another and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bd15628987b213ea64bd0e189c0539be
https://doi.org/10.1158/1538-7445.sabcs21-p2-14-12

Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery

Autor: Katrien Geboers, Jean-Charles Goeminne, B. Petit, Hans Wildiers, Abdelbari Baitar, R.E.N. van Rijswijk, Lore Decoster, Pol Specenier, Frank Cornelis, Michelle Lycke, Christian Bachmann, Sylvie Luce, Gwenaëlle Debugne, D. Bron, H. Van den Bulck, Philip R. Debruyne, C. Focan, Chantal Quinten, Johan Flamaing, Koen Milisen, J.-P. Praet, Vincent Verschaeve, K. Vandenborre, Jean-Pierre Lobelle, I. De Groof, Christine Langenaeken, Cindy Kenis, Guy Jerusalem

Publikováno v: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, (2018)
Quality of life research

PURPOSE: Using the EORTC Global Health Status (GHS) scale, we aimed to determine minimal clinically important differences (MCID) in health-related quality of life (HRQOL) changes for older cancer patients with a geriatric risk profile, as defined by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::113794c68c69caf9cf261ac2a918bf43
https://doi.org/10.1007/s11136-018-2062-6

The prognostic value of patient-reported Health-Related Quality of Life and Geriatric Assessment in predicting early death in 6769 older (≥ 70 years) patients with different cancer tumors

Autor: Johan Flamaing, Dominique Bron, B. Petit, Vincent Verschaeve, K. Vandenborre, Philip R. Debruyne, Heidi Van den Bulck, Frank Cornelis, Christine Langenaeken, Guy Jerusalem, Dirk Schrijvers, Chantal Quinten, J.-P. Praet, Michelle Lycke, Ruud Van Rijswijk, Cindy Kenis, Jean-Charles Goeminne, Hans Wildiers, Syvlie Luce, Lore Decoster, Christian Bachmann, Inge De Groof, Jean-Pierre Lobelle, Pol Specenier, Katrien Geboers, Gwenaëlle Debugne, Christian Focan, Koen Milisen

Publikováno v: Journal of geriatric oncology, Vol. 11, no. 6, p. 926-936 (2020)
Journal of Geriatric Oncology

Objectives: We aimed to determine the prognostic value of baseline Health-Related Quality Of Life (HRQOL) and geriatric assessment (GA) to predict three-month mortality in older patients with cancer undergoing treatment. Methods: Logistic regressions

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fadc8e80e5a9f7bb83a8bb85c051ab0
https://hdl.handle.net/2078.1/229734

Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib

Autor: Evelyne Lerut, Vincent Verschaeve, Diether Lambrechts, A. Mejean, Thomas Van Brussel, Gabrielle Couchy, Stéphane Oudard, Patrick Schöffski, Jessica Zucman-Rossi, Vincent Richard, Herlinde Dumez, Annelies Verbiest, Maxime Vanmechelen, Benoit Beuselinck, Pascal Wolter, Jean-Pascal Machiels, Maarten Albersen, Philip R. Debruyne

Publikováno v: Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, Elsevier, 2019, 17 (2), pp.e235-e246. ⟨10.1016/j.clgc.2018.11.002⟩
Clinical genitourinary cancer, Vol. 17, no. 2, p. e235-e246 (2019)
Clinical genitourinary cancer, Vol. 17, no.2, p. e235-e246 (2019)

BACKGROUND: There are no validated markers that predict response or resistance in patients with metastatic clear-cell renal cell carcinoma (mccRCC) treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors such as sunitinib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::267696fc3565eb45ecb700ffc7ddd240
https://www.hal.inserm.fr/inserm-02532766/document